Evaluating a New Test for Invasive Candidiasis
Author Information
Author(s): Gourav Sudesh, Singh Gagandeep, Kashyap Lokesh, Rana Bhaskar, Raj Swet, Xess Immaculata
Primary Institution: All India Institute of Medical Sciences, New Delhi, India
Hypothesis
The study aimed to assess the diagnostic performance of the FungiXpert® Fungus BDG Detection Kit for diagnosing invasive candidiasis.
Conclusion
The FungiXpert® Fungus BDG Detection Kit showed acceptable performance for diagnosing invasive candidiasis in a resource-limited setting.
Supporting Evidence
- The sensitivity of the BDG assay for proven invasive candidiasis was 60.52%.
- The specificity of the BDG assay was 81.81%.
- The overall mortality rate was significantly higher in the BDG positive group (65.62%) compared to the negative group (33.33%).
- The assay performed best for Candida tropicalis with a sensitivity of 92.3%.
- Median serum BDG was 0.63 ng/ml for proven IC and 0.04 ng/ml for no IC.
Takeaway
Researchers tested a new kit to help doctors find a serious fungal infection called invasive candidiasis, and it worked pretty well.
Methodology
This was a prospective case-control study involving 80 patients, where blood samples were collected for fungal culture and BDG assay.
Potential Biases
Reliance on provided history for patient categorization could introduce bias.
Limitations
The study had a relatively small sample size and did not systematically assess Candida colonization.
Participant Demographics
The study included 80 patients, with 34 males and 46 females, and a median age of 35 years.
Statistical Information
P-Value
0.003
Confidence Interval
95% CI: 43–75
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website